Host: |
Rabbit |
Applications: |
WB/IHC/IF/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Ubiquitin carboxyl-terminal hydrolase 19 (391-440 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000IHC 1:100-1:300ELISA 1:20000IF 1:50-200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
USP19 |
Gene ID: |
10869 |
Uniprot ID: |
UBP19_HUMAN |
Immunogen Region: |
391-440 aa |
Specificity: |
USP19 Polyclonal Antibody detects endogenous levels of USP19 protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human USP19 at the amino acid range 391-440 |
Protein Name | Ubiquitin Carboxyl-Terminal Hydrolase 19Deubiquitinating Enzyme 19Ubiquitin Thioesterase 19Ubiquitin-Specific-Processing Protease 19Zinc Finger Mynd Domain-Containing Protein 9 |
Database Links | Reactome: R-HSA-5689880 |
Cellular Localisation | Endoplasmic Reticulum MembraneSingle-Pass Membrane Protein |
Alternative Antibody Names | Anti-Ubiquitin Carboxyl-Terminal Hydrolase 19 antibodyAnti-Deubiquitinating Enzyme 19 antibodyAnti-Ubiquitin Thioesterase 19 antibodyAnti-Ubiquitin-Specific-Processing Protease 19 antibodyAnti-Zinc Finger Mynd Domain-Containing Protein 9 antibodyAnti-USP19 antibodyAnti-KIAA0891 antibodyAnti-ZMYND9 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance